Skip to main content
Premium Trial:

Request an Annual Quote

Waters Donates Synapt Mass Spec System to Research Center

NEW YORK (GenomeWeb News) – Waters today said that it has donated a Synapt MS System, its latest generation of mass spectrometers, to a Quebec-based research center for screening, clinical diagnosis, and assessment of treatments for specific hereditary diseases.
 
The mass spec system was donated to the Foundation du centre hospitalier universitaire de Sherbrooke and will be used by the Waters-CHUS Expertise Center for Clinical Mass Spectrometry, a collaboration between the hospital and Waters. Waters said that the gift was worth around C$1.1 million (US$893,000).
 
“This mass spectrometer will enable us to identify previously unknown biomarkers, that is, characteristics that can be objectively measured biochemically as indicators of pathogenic processes,“ Christiane Auray-Blais, scientific director of the Waters-CHUS center, said in a statement. “This will enable us to better understand certain diseases, such as Fabry disease, establish correlations with the severity of the disorder, screen patients earlier, offer more effective treatment, and deliver better management.”
 

The Scan

Self-Reported Hearing Loss in Older Adults Begins Very Early in Life, Study Says

A JAMA Otolaryngology — Head & Neck Surgery study says polygenic risk scores associated with hearing loss in older adults is also associated with hearing decline in younger groups.

Genome-Wide Analysis Sheds Light on Genetics of ADHD

A genome-wide association study meta-analysis of attention-deficit hyperactivity disorder appearing in Nature Genetics links 76 genes to risk of having the disorder.

MicroRNA Cotargeting Linked to Lupus

A mouse-based study appearing in BMC Biology implicates two microRNAs with overlapping target sites in lupus.

Enzyme Involved in Lipid Metabolism Linked to Mutational Signatures

In Nature Genetics, a Wellcome Sanger Institute-led team found that APOBEC1 may contribute to the development of the SBS2 and SBS13 mutational signatures in the small intestine.